Today Anteo Technologies Pty Ltd (a subsidiary of Anteo Diagnostics Limited, ASX: ADO) is pleased to announce the launch of a research partnership with the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland. The partnership is to be funded by the University’s Collaboration and Industry Engagement Fund (CIEF) grants program.
“Anteo Technologies is an important partner of the AIBN and is an active participant in the institute’s Industrial Affiliate Program. We are confident that this research partnership will enhance the likelihood of success for future funding applications to ARC Linkage or NHMRC Development schemes.” – Professor Andrew Whittaker, AIBN, UQ
The impact of refining and improving outcomes in medical and diagnostic imaging could deliver substantial improvements in patient outcomes.